Publications by authors named "Matuskova V"

Aim:  To retrospectively evaluate the anatomical and functional success of surgical treatment of rhegmatogenous retinal detachment (RRD) in the only remaining seeing eye.

Material And Methods:  The study included 28 eyes of 28 patients, 19 (68%) of whom were men, with an average age of 46 years. They were operated on by a single surgeon for RRD at the Eye Clinic of the University Hospital and Faculty of Medicine, Masaryk University in Brno, from July 1, 2019, to April 30, 2023, using cryosurgical techniques and/or 25G+ pars plana vitrectomy (PPV).

View Article and Find Full Text PDF

Neuropsychiatric symptoms (NPS) are common in hereditary ataxias as a part of the cerebellar cognitive affective syndrome. In Friedreich ataxia (FRDA), one of the most common hereditary ataxias, depressive symptoms were previously reported, but little is known about other NPS. We aimed to study the presence and severity of a broad range of NPS in individuals with FRDA and assess the relationship between the NPS and the disease severity, cognition, and quality of life and to examine the concordance between the NPS reported by the patients and by their informants.

View Article and Find Full Text PDF

Background: The aim of this study was to evaluate the significance of testing the gain of chromosome 8 and the gain of chromosome 6 as prognostic markers in histopathological samples of enucleated eyes in with uveal melanoma.

Methods: This is a retrospective study of 54 enucleated eyes. The status of chromosomes 3, 8 and 6 was tested by CISH, and FISH was used in a few samples.

View Article and Find Full Text PDF

Aims: Autoantibodies against hexokinase 1 (HK1) were recently proposed to be associated with diabetic macular edema (DME). We hypothesized that anti-HK1 autoantibodies can be used as DME markers and to predict DME onset.

Materials And Methods: Serum from patients with 1) DME, 2) diabetes mellitus (DM), 3) allergies or autoimmunities, and 4) control subjects was tested for anti-HK1 and anti-hexokinase 2 (HK2) autoantibodies by immunoblotting.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates mitophagy impairment in Alzheimer's disease (AD) by examining biomarkers in serum and cerebrospinal fluid (CSF) from 246 individuals, including those with mild cognitive impairment (MCI-AD), AD dementia, and cognitively unimpaired individuals.
  • The results indicate that certain biomarkers (PINK1, BNIP3L, TFEB) were differently expressed in individuals with AD compared to those who were cognitively unimpaired, suggesting a link between mitophagy impairment and AD pathology.
  • Moreover, the levels of these biomarkers correlated with cognitive function and clinical indicators of AD severity, highlighting the potential of mitophagy biomarkers as indicators for disease progression.
View Article and Find Full Text PDF

Objective: This study aims to evaluate the efficacy of the Uniform Data Set (UDS) 2 battery in distinguishing between individuals with mild cognitive impairment (MCI) attributable to Alzheimer's disease (MCI-AD) and those with MCI due to other causes (MCI-nonAD), based on contemporary AT(N) biomarker criteria. Despite the implementation of the novel UDS 3 battery, the UDS 2 battery is still used in several non-English-speaking countries.

Methods: We employed a cross-sectional design.

View Article and Find Full Text PDF

Aim: The aim of the study is to retrospectively evaluate the anatomical success rate and functional results of 25G+ PPV in the treatment of newly diagnosed rhegmatogenous retinal detachment (RRD).

Material And Methods: The set consists of 152 eyes of 152 patients, of which 71 (47%) were men, average age 54 years, operated on by one surgeon for RRD at the Eye Clinic of the University Hospital and Medical Faculty of Masaryk University Brno from 1.7.

View Article and Find Full Text PDF

Background: Mild behavioral impairment (MBI) has been commonly reported in early Alzheimer's disease (AD) but rarely using biomarker-defined samples. It is also unclear whether genetic polymorphisms influence MBI in such individuals. We thus aimed to examine the association between the cognitive status of participants (amnestic mild cognitive impairment (aMCI-AD) vs cognitively normal (CN) older adults) and MBI severity.

View Article and Find Full Text PDF

Apart from its role in motor coordination, the importance of the cerebellum in cognitive and affective processes has been recognized in the past few decades. Spinocerebellar ataxias (SCA) and Friedreich ataxia (FRDA) are rare neurodegenerative diseases of the cerebellum presenting mainly with a progressive loss of gait and limb coordination, dysarthria, and other motor disturbances, but also a range of cognitive and neuropsychiatric symptoms. This narrative review summarizes the current knowledge on neuropsychiatric impairment in SCA and FRDA.

View Article and Find Full Text PDF

Despite the rising global burden of stroke and its socio-economic implications, the neuroimaging predictors of subsequent cognitive impairment are still poorly understood. We address this issue by studying the relationship of white matter integrity assessed within ten days after stroke and patients' cognitive status one year after the attack. Using diffusion-weighted imaging, we apply the Tract-Based Spatial Statistics analysis and construct individual structural connectivity matrices by employing deterministic tractography.

View Article and Find Full Text PDF

Introduction: Choroid plexus (CP)-related mechanisms have been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease. In this pilot study, we aimed to elucidate the association between longitudinal changes in CP volume, sex and cognitive impairment.

Methods: We assessed longitudinal changes in CP volume in a cohort of  = 613 subjects across  = 2,334 datapoints from ADNI 2 and ADNI-GO, belonging to cognitively unimpaired (CN), stable mild cognitive impairment (MCI), clinically diagnosed Alzheimer's disease dementia (AD) or convertor (to either AD or MCI) subgroups.

View Article and Find Full Text PDF

Isoprenoid cytokinins are a class of naturally occurring plant signaling molecules. A series of prepared compounds derived from isoprenoid cytokinins (isopentenyladenine, trans-zeatin and cis-zeatin) with attached 2'-deoxy-d-ribose or 2',3'-dideoxy-d-ribose at the N position of the purine were prepared and their biological activities were examined. Different synthetic approaches were employed.

View Article and Find Full Text PDF

Purpose: The aim of the study was to compare the effect of three initial doses of the anti-VEGF ranibizumab and aflibercept medication on serous pigment epithelial detachment (PED), subretinal fluid (SRF) and intraretinal fluid (IRF) in the macula of treatment naive neovascular AMD (nvAMD) patients.

Material And Methods: The cohort consists of 148 patients, of which 74 patients were treated with ranibizumab (51 females and 23 males) and 74 with aflibercept (46 females and 28 males). The data was recorded prospectively from the moment of diagnosis and start of treatment for a period of 3 months.

View Article and Find Full Text PDF
Article Synopsis
  • The CECR memory test is explored for its effectiveness in predicting dementia progression in patients with amnestic mild cognitive impairment (aMCI), compared to other memory tests.
  • A study involving 270 aMCI patients found that 53% converted to dementia, mainly due to Alzheimer's or mixed dementia.
  • Results indicated that traditional verbal memory tests (AVLT and LM) were more predictive of dementia conversion than the CECR-based test, suggesting no significant advantage of CECR in clinical assessments.
View Article and Find Full Text PDF

Background: Spatial navigation impairment is a promising cognitive marker of Alzheimer's disease (AD) that can reflect the underlying pathology.

Objectives: We assessed spatial navigation performance in AD biomarker positive older adults with amnestic mild cognitive impairment (AD aMCI) vs. those AD biomarker negative (non-AD aMCI), and examined associations between navigation performance, MRI measures of brain atrophy, and cerebrospinal fluid (CSF) biomarkers.

View Article and Find Full Text PDF
Article Synopsis
  • This text indicates there is a correction to be made regarding the article identified by the DOI 10.3389/fnagi.2021.643271.
  • It suggests that there may have been errors or updates that need to be addressed in the original publication.
  • The DOI provided helps researchers and readers locate the specific article for further details on the correction.
View Article and Find Full Text PDF

Background: Older adults with subjective cognitive decline (SCD) are at an increased risk of progression to mild cognitive impairment (MCI) or dementia. However, few have examined the specific cognitive tests that are associated with progression.

Objective: This study examined performance on 18 neuropsychological tests among participants with SCD who later progressed to MCI or dementia.

View Article and Find Full Text PDF
Article Synopsis
  • Innovative memory tests, specifically the Memory Binding Test (MBT), were developed to detect early memory changes in Alzheimer's disease (AD).
  • The study analyzed how MBT results related to hippocampal volume (HV) in individuals with subjective cognitive decline (SCD), amnestic mild cognitive impairment (aMCI), and cognitively normal (CN) older adults.
  • Results indicated that MBT scores, particularly in immediate and delayed recall, showed stronger associations with lower HV compared to traditional verbal memory tests, highlighting MBT's potential for early detection of memory decline related to hippocampal issues.
View Article and Find Full Text PDF

Age-related spatial navigation decline is more pronounced in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. We used a realistic-looking virtual navigation test suite to analyze different aspects of visuospatial processing in typical and atypical aging. A total of 219 older adults were recruited from the Czech Brain Aging Study cohort.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to evaluate the long-term efficacy, safety, immunogenicity, and pharmacokinetics of the ranibizumab biosimilar SB11 compared to the original ranibizumab (RBZ) in patients with neovascular age-related macular degeneration (nAMD).
  • Conducted as a multicenter, randomized, double-masked, parallel-group phase III equivalence trial with 705 participants, the study involved monthly intravitreal injections of either SB11 or RBZ and followed participants for 52 weeks.
  • Results showed comparable visual outcomes, safety profiles, and immune responses between SB11 and RBZ, confirming that SB11 is a suitable alternative to RBZ in treating nAMD.
View Article and Find Full Text PDF

Objectives: Mild behavioral impairment (MBI) is a syndrome describing late-onset persistent neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have investigated the associations of MBI with structural brain changes. Our aim was to explore structural correlates of NPS in a non-demented memory clinic sample using the Mild Behavioral Impairment Checklist (MBI-C) that has been developed to measure MBI.

View Article and Find Full Text PDF

Background: Identifying modifiable risk factors for cognitive decline can reduce burden of dementia.

Objective: We examined whether homocysteine was associated with memory performance, mediated by entorhinal volume, hippocampal volume, total gray matter volume, or white matter lesions, and moderated by APOE ɛ4 allele, B vitamins, creatinine, total cholesterol, or triglycerides.

Methods: All 204 members of the Czech Brain Aging Study with subjective cognitive decline (SCD; n = 60) or amnestic mild cognitive impairment (aMCI; n = 144) who had valid data were included.

View Article and Find Full Text PDF

Background: The apolipoprotein E (APOE) ɛ4 allele is associated with episodic memory and spatial navigation deficits. The brain-derived neurotrophic factor (BDNF) Met allele may further worsen memory impairment in APOEɛ4 carriers but its role in APOEɛ4-related spatial navigation deficits has not been established.

Objective: We examined influence of APOE and BDNF Val66Met polymorphism combination on spatial navigation and volumes of selected navigation-related brain regions in cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (aMCI).

View Article and Find Full Text PDF
Article Synopsis
  • Neovascular age-related macular degeneration is a major cause of blindness in people over 50, and the ranibizumab biosimilar (SB11) could provide a more accessible treatment option.
  • A phase 3 study involving 705 participants was conducted across 75 centers in multiple countries to compare the efficacy, safety, and immunogenicity of SB11 to the reference drug ranibizumab.
  • Results showed that the visual acuity and central subfield thickness improvements were similar between the two treatments, indicating that SB11 is a viable alternative to ranibizumab.
View Article and Find Full Text PDF